EQS-News: Medios AG significantly expands compounding capacity at Berlin site – manufacturing permit granted for new laboratory
EQS-News: Medios AG
/ Key word(s): Miscellaneous
Press release Berlin, October 27, 2022 – Medios AG ("Medios"), the leading provider of Specialty Pharma Solutions in Germany, yesterday received the manufacturing permit for the new GMP (Good Manufacturing Practice) clean room laboratory in Berlin from the responsible authority (Landesamt für Gesundheit und Soziales; "LaGeSo"). A major milestone has thus been reached, helping to increase of the Medios Group's manufacturing capacity in the higher-margin Patient-Specific Therapies business segment to up to 600,000 preparations per year (2021: around 320,000 preparations (pro forma: Medios including NewCo Pharma)). For the new logistics center and the new laboratory site, Medios AG had rented a new building which covers a total area of approximately 4,500 square meters. The investments for the necessary refurbishment were primarily made in the 2021 financial year and amounted to around €11 million. The new laboratory will start mid-November with the production of preparations for partner pharmacies of the Medios Group. 1 DGNB: Deutsche Gesellschaft für Nachhaltiges Bauen (German Sustainable Building Council) ------------------- About Medios AG www.medios.ag www.medios.ag Disclaimer
27.10.2022 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG. |
Language: | English |
Company: | Medios AG |
Heidestraße 9 | |
10557 Berlin | |
Germany | |
Phone: | +49 30 232 566 - 800 |
Fax: | +49 30 232 566 - 801 |
E-mail: | [email protected] |
Internet: | www.medios.ag |
ISIN: | DE000A1MMCC8 |
WKN: | A1MMCC |
Indices: | SDAX |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
EQS News ID: | 1473139 |
End of News | EQS News Service |
|
1473139 27.10.2022 CET/CEST
Medios AG Aktie
Leichte Kaufneigung bei Medios AG, mit mehr Buy- als Sell-Einschätzungen.
Das Kursziel von 25 € für Medios AG bedeutet eine deutliche Steigerung von über 50% gegenüber dem aktuellen Kurs von 14.34 €.